Dr. Ralph Alhalel, MD

Dr. Alhalel practices at Rio Grande Gastroenterology Consultants in Mcallen, Texas.

Dr. Alhalel's NPI, 1700830353, was assigned on May 19, 2006. Dr. Alhalel graduated from National University of San Marcos in 1988. Dr. Alhalel holds Texas license J1839.

Dr. Alhalel's primary practice is Rio Grande Gastroenterology Consultants, at 1200 E Ridge Rd, Mcallen, TX 78503 in Hidalgo County. The practice phone is (956) 661-9300.

Dr. Alhalel's primary practice is Rio Grande Gastroenterology Consultants in Mcallen, Texas. Dr. Alhalel is also affiliated with Rio Grande Regional Hospital. The medical group on file is Rio Grande Gastroenterology Consultants. Dmand AI also links Dr. Alhalel to 3 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alhalel practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Alhalel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Alhalel is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Alhalel is licensed in Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Alhalel treats.

CMS data shows 1,182 Medicare services from Dr. Alhalel across 11 procedure codes in 2024, for 428 Medicare patients. Medicare paid $87,797 for them.

CMS counts 428 Medicare patients who saw Dr. Alhalel in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alhalel's median patient age at 65, with 58% women.

In 2024, Dr. Alhalel wrote 1,437 Medicare Part D claims for 605 patients. 79% of them were for generic drugs. CMS names the drug for 1,254 of them, across 20 drugs with 11 or more claims each, at $734,144 in total drug cost. In 2023, CMS named 3,540 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Alhalel for performance year 2024, reported individually. Dr. Alhalel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 125 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Alhalel, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Alhalel. The most frequent topics are Sphincterotomy, Endoscopic and Cholangiopancreatography, Endoscopic Retrograde.

Dmand AI links Dr. Alhalel to 4 clinical trials. Conditions studied include Rectal Diseases, Colorectal Neoplasms and Crohn Disease. Exact Sciences Corporation sponsors the most, 2. Open Payments lists research payments to Dr. Alhalel that name 1 trial.

CMS Open Payments shows 367 general payments to Dr. Alhalel from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Abbvie Inc. paid the most, $2,871. It also lists 4 research payments totaling $10,075 from 2019 to 2022, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Alhalel, most recently Board Member Universal Health Services in 2019.

Dr. Alhalel graduated from National University of San Marcos in 1988. Dr. Alhalel is a member of ACG, AGA and American Society of Gastrointestinal Endoscopy.

Dr. Alhalel is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.